GT 002Alternative Names: GT002
Latest Information Update: 25 Jul 2016
At a glance
- Originator Lund University
- Developer Gabather; University of New South Wales
- Class Small molecules
- Mechanism of Action GABA A receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Psychotic disorders